Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 23;15(6):972-978.
doi: 10.1021/acsmedchemlett.4c00206. eCollection 2024 Jun 13.

Novel 2,4-Dichloro-5-sulfamoylbenzoic Acid Oxime Esters: First Studies as Potential Human Carbonic Anhydrase Inhibitors

Affiliations

Novel 2,4-Dichloro-5-sulfamoylbenzoic Acid Oxime Esters: First Studies as Potential Human Carbonic Anhydrase Inhibitors

Jaydeo T Kilbile et al. ACS Med Chem Lett. .

Abstract

In this study, a focused library of oxime ester derivatives of 2,4-dichloro-5-sulfamoylbenzoic acid (lasamide) containing Schiff bases was synthesized and tested in vitro for their ability to inhibit the cytosolic human carbonic anhydrases (hCAs) I and II, as well as the transmembrane and tumor-associated IX and XII isoforms. As a result, we obtained a first line of knowledge on lasamide derivatives potentially useful for development as CA inhibitors (CAIs). In particular, we focused our attention on the derivative 11, which was selective toward hCAs IX and XII over the cytosolic isoenzymes. An in silico study was conducted to assess the binding mode of 11 within hCAs IX and XII. Also, antiproliferative assays highlighted promising derivatives. The data obtained in this study are currently in use for the development of better-performing compounds on the tumor-associated isoforms.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Scheme 1
Scheme 1. Synthetic Approach for Oxime Ester Series (4–16) of Lasamide 1 Reported in This Work
Reagents and conditions: (i) SOCl2, toluene, 45 °C, 6 h; (ii) N-Boc-hydroxylamine, TEA, THF, 5 °C to rt, 10 h; (iii) TFA, DCM, 5 °C, 5 h; (iv) aldehyde or ketone, AcONa, EtOH, 75 °C, 5 h.
Figure 1
Figure 1
Chemical structures of O-benzoyl oximes 416.
Figure 2
Figure 2
Predicted binding mode of compound 11 against the crystallographic structure of (A) hCA IX (orange cartoons and lines) and (C) hCA XII (gold cartoons and lines). Compound 11 is shown as cyan sticks, and the catalytic Zn (II) ion is shown as a gray sphere. Polar interactions in panels (A) and (C) are highlighted by black dashed lines, and residues contacted by the ligand are shown as sticks. In panels (B) and (D), the overlay between the docking pose of compound 11 and the cocrystallized AAZ (colored gray) is shown.
Figure 3
Figure 3
Cells proliferation of triple-negative breast cancer MDA-MB-231 cells treated for 72 h with 4, 11, 12, and SLC-0111. Cell count refers to the untreated/control as 100%.

Similar articles

Cited by

References

    1. Siegel R. L.; Miller K. D.; Wagle N. S.; Jemal A. Cancer Statistics, 2023. CA: A Cancer Journal for Clinicians 2023, 73 (1), 17–48. 10.3322/caac.21763. - DOI - PubMed
    1. Nerella S. G.; Thacker P. S.; Arifuddin M.; Supuran C. T. Tumor Associated Carbonic Anhydrase Inhibitors: Rational Approaches, Design Strategies, Structure Activity Relationship and Mechanistic Insights. European Journal of Medicinal Chemistry Reports 2024, 10, 100131 10.1016/j.ejmcr.2024.100131. - DOI
    1. Angeli A.; Chelli I.; Lucarini L.; Sgambellone S.; Marri S.; Villano S.; Ferraroni M.; De Luca V.; Capasso C.; Carta F.; Supuran C. T. Novel Carbonic Anhydrase Inhibitors with Dual-Tail Core Sulfonamide Show Potent and Lasting Effects for Glaucoma Therapy. J. Med. Chem. 2024, 67 (4), 3066–3089. 10.1021/acs.jmedchem.3c02254. - DOI - PubMed
    1. Supuran C. T. Structure and Function of Carbonic Anhydrases. Biochem. J. 2016, 473 (14), 2023–2032. 10.1042/BCJ20160115. - DOI - PubMed
    1. McDonald P. C.; Chafe S. C.; Supuran C. T.; Dedhar S. Cancer Therapeutic Targeting of Hypoxia Induced Carbonic Anhydrase IX: From Bench to Bedside. Cancers (Basel) 2022, 14 (14), 3297. 10.3390/cancers14143297. - DOI - PMC - PubMed

LinkOut - more resources